Turn Therapeutics Stock
Turn Therapeutics Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Bradley E. Burnam
- Employees
- 2
- Market cap
- $315 M
- IPO
- 08/10/2025
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This…
Turn Therapeutics stock: price history
1D
-8.8%
1W
-11.9%
1M
-23.0%
6M
+205.5%
YTD
+168.3%
1Y
+87.4%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~36% stronger price swings than usual
Ask the agents about Turn Therapeutics
Analyst assessment of Turn Therapeutics
0
STRONG BUY
1
BUY
0
HOLD
1
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 14/09/2026
Turn Therapeutics stock metrics
P/E
-36.27
P/B
458.39
EV/EBITDA
-74.55
RETURN ON EQUITY
-851.6%
NET MARGIN
0.0%
DEBT/EQUITY
8.91
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
36.4%
FLOAT SHARES
10,828,548
AVG. DAILY VOLUME (30D)
154,948
Insider transactions (SEC)
Burnam Bradley Evan
Burnam Bradley Evan
Burnam Bradley Evan
Burnam Bradley Evan
Institutional holders
Comparable stocks
Frequently asked questions about Turn Therapeutics stock
What does Turn Therapeutics do?
Turn Therapeutics Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Bradley E. Burnam, the company employs around 2 people.
The IPO was on 08/10/2025; the stock trades on NASDAQ under the ticker TTRX.
What do analysts say about Turn Therapeutics stock?
2 analysts rate the stock, the consensus is Buy (as of 14/09/2026).
This is an external assessment, not a statement by Market Jury.
When does Turn Therapeutics report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 36% stronger than usual.
Does Turn Therapeutics pay a dividend?
No, Turn Therapeutics currently does not pay a dividend.
Which stocks are comparable to Turn Therapeutics?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Turn Therapeutics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Turn Therapeutics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.